Breaking News

SGS Launches New Capabilities in China

Introduces drug compatibility study testing at expanded Shanghai facility

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

SGS has introduced comprehensive drug compatibility study testing at its Shanghai laboratory in China. This new service, for the analysis of potential extractable and leachable contamination within pharmaceutical products, harmonizes services offered in this field across SGS’s global network of laboratories. China’s Center for Drug Evaluation (CDE) made drug compatibility studies mandatory for all New Drug Applications (NDAs) and Abbreviated New Drug Applications (ANDAs) in 2014. SGS’s invest...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters